Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy

Expert Opinion on Drug Delivery

Volumn 6, Issue 8, 2009, Pages 865-878

  Gindy, Marian E ^a,b   Prud'homme, Robert K ^a  

^a PRINCETON UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Diagnostics; Drug delivery; Flash NanoPrecipitation; Imaging; Multifunctional; Nanoparticle

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; DAUNORUBICIN; DENDRIMER; DEXTRAN; DOXORUBICIN; FERUCARBOTRAN; FERUMOXSIL; FOLIC ACID; GEMTUZUMAB OZOGAMICIN; GOLD NANOPARTICLE; IBRITUMOMAB TIUXETAN; IT 101; LIPOSOME; MBP 426; MBP 462; MONOCLONAL ANTIBODY; NANOCARRIER; NANOPARTICLE; ONCO TCS; PACLITAXEL; PACLITAXEL POLIGLUMEX; POLYMER; SFT 53; SILICON DIOXIDE; SP 1049C; SUPERPARAMAGNETIC IRON OXIDE; TOSITUMOMAB I 131; TRASTUZUMAB; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

CANCER THERAPY; CLINICAL TRIAL; DRUG APPROVAL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; DRUG TARGETING; FLUORESCENCE IMAGING; HUMAN; LIPOSOMAL DELIVERY; NANOENGINEERING; NANOIMAGING; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOTHERAPY; REVIEW;

ANTINEOPLASTIC AGENTS; DIAGNOSTIC IMAGING; DRUG CARRIERS; HUMANS; NANOPARTICLES; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 68149163521     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240902932908     Document Type: Review

References (102)

1. United States Centers for Disease Control and Prevention (CDC). Cancer Statistics. Cancer Incidence and Mortalitity Data 2007. Available from: http://apps.nccd. cdc.gov/uscs/
2. American Cancer Society. Cancer Facts and Figures 2008. Available from: http://www.cancer.org/downloads/STT/2008CAFFfinalseculred.pdf.
3. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005;5(3):161-171
4. Nie S, Xing Y, Kim GJ, et al. Nanotechnology applications in cancer. Annu Rev Biomed Eng 2007;9:257-288
5. Fukumori Y, Ichikawa H. Nanoparticles for cancer therapy and diagnosis. Adv Powder Technol 2006;17(1):1-28
6. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002;54(5):631-651
7. Portney NG, Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem 2006;384(3):620-630 (Pubitemid 43237915)
8. Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006;58(14):1532-1555
9. Kataoka K, Matsumoto T, Yokoyama M, et al. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Colloid Interface Sci 2000;64(1-3):143-153 (Pubitemid 30035315)
10. Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carrier Syst 2003;20(5):357-403 (Pubitemid 38129592)
11. Cho KJ, Wang X, Nie SM, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14(5):1310-1316
12. Allen TM. Long-circulating (Sterically Stabilized) liposomes for targeted drug-delivery. Trends Pharmacol Sci 1994;15(7):215-220
13. Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci 2003;92(7):1343-1355 (Pubitemid 36792748)
14. Woodle MC. Sterically stabilized liposome therapeutics. Adv Drug Deliv Rev 1995;16:249-265
15. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001;47(1):113-131 (Pubitemid 32209236)
16. Gupta RB, Kompella UB. Nanoparticle Technology for Drug Delivery. Drugs and the Pharmaceutical Sciences. Vol.159. 2006, New York: Taylor and Francis Group, LLC
17. Kim S. Liposomes as carriers of cancer-chemotherapy - current status and future-prospects. Drugs 1993;46(4):618-638 (Pubitemid 23331062)
18. Gregoriadis G, Florence AT. Liposomes in drug delivery - clinical, diagnostic and ophthalmic potential. Drugs 1993;45(1):15-28 (Pubitemid 23093890)
19. LaVan DA, Lynn DM, Langer R. Moving smaller in drug discovery and delivery. Nat Rev Drug Discov 2002;1(1):77-84 (Pubitemid 37361406)
20. Shuai XT, Ai H, Nasongkla N, et al. Micellar carriers based on block copolymers of poly(e-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release 2004;98(3):415-426 (Pubitemid 39093952)
21. Moghimi SM. Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology. Anti Cancer Agents Med Chem 2006;6:553-561
22. Couvreur P, Dubernet C, Puisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm 1995;41(1):2-13
23. Kwon GS. Diblock copolymer nanoparticles for drug delivery. Crit Rev Ther Drug Carrier Syst 1998;15(5):481-512
24. Kim DW, Kim SY, Kim HK, et al. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol 2007;18(12):2009-2014
25. Danson S, Ferry D, Alakhov V, et al. Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer 2004;90:2085-2091 (Pubitemid 38869710)
26. Heath JR, Davis ME. Nanotechnology and cancer. Annu Rev Med 2008;59:251-265
27. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics; an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-782
28. Bonnemann H, Richards RM. Nanoscopic metal particles - synthetic methods and potential applications. Eur J Inorg Chem 2001;2455-2480 (Pubitemid 32943557)
29. Alekseeva AV, Bogatyrev VA, Khlebtsov BN, et al. Gold nanorods: synthesis and optical properties. Colloid J 2006;68(6):661-678 (Pubitemid 44925226)
30. Mornet S, Vasseur S, Grasset F, et al. Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 2004;14(14):2161-2175
31. Durr NJ, Larson T, Smith DK, et al. Two-photon luminescence imaging of cancer cells using molecularly targeted nanorods. Nano Lett 2007;7:941-945 (Pubitemid 46717737)
32. Hainfeld JF, Slatkin DN, Focella TM, et al. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006;79(939):248-253
33. Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. Nmr Biomed 2004;17(7):484-499 (Pubitemid 39549426)
34. Sun C, Lee JSH, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008;60(11):1252-1265
35. Karabutova AA, Savateeva EV, Oraevsky AA. Optoacoustic tomography: new modality of laser diagnostic systems. Laser Phys 2003;13(5):711-723
36. Kolkman R, Steenbergen W, van Leeuwen TG. In vivo photoacoustic imaging of blood vessels with a pulsed laser diode. Lasers Med Sci 2006;21(3):134-139
37. Kim K, Huang SW, Ashkenazi S, et al. Photoacoustic imaging of early inflammatory response using gold nanorods. Appl Phys Lett 2007;90(22):223901 (Pubitemid 46872679)
38. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307(5709):538-544 (Pubitemid 40165671)
39. Pinaud F, Michalet X, Bentolila LA, et al. Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials 2006;27(9):1679-1687 (Pubitemid 41759461)
40. Huang XH, El-Sayed IH, Qian W, et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006;128(6):2115-2120 (Pubitemid 43277351)
41. Hirsch LR, Stafford RJ, Bankson JA, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003;100:13549-13554
42. Ivkov R, DeNardo SJ, Daum W, et al. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res 2005;11:733-739
43. Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Drug Discov 2002;2:750-763
44. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003;2:347-360
45. Moghimi SM, Hunter CA, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001;53(2):283-318
46. Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93-102 (Pubitemid 41773257)
47. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 2003;55:403-419 (Pubitemid 36293792)
48. Bazile D, Prudhomme C, Bassoullet MT, et al. Stealth me.peg-pla nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 1995;84(4):493-498
49. Jeon SI, Lee JH, Andrade JD, et al. Protein-surface interactions in the presence of polyethylene oxide. I. Simplified theory. J Colloid Interface Sci 1991;142(1):149-158
50. Garnett MC. Adv Drug Deliv Rev 2001;53:171-216
51. Taylor AE, Granger DN. Equivalent pore modeling - vesicles and channels. Federation Proc 1983;42(8):2440-2445
52. Winter PM, Caruthers SD, Kassner A, et al. Molecular imaging of angiogenesis in nascent vx-2 rabbit tumours using a novel alpha(v)beta(3)- targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 2003;63:5838-5843
53. Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998;95(8):4607-4612 (Pubitemid 28207960)
54. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting, in advances in enzyme regulation. 2001;41:189-207
55. Chavanpatil MD, Khdair A, Panyam J. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J Nanosci Nanotechnol 2006;6(9-10):2651-2663 (Pubitemid 44579937)
56. Torchilin VP. Drug targeting. Eur J Pharm Sci 2000;11:S81-91
57. Yokoyama M, Okano T, Sakurai Y, et al. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier ssytem. J Drug Target 1999;7:171-186 (Pubitemid 30028961)
58. Yuan F. Vascular-permeability in human tumor xenograft-molecular-size dependence and cuttoff size. Cancer Res 1995;55:3752-3756
59. Torchilin V. Recent advances in lioposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-160 (Pubitemid 40282557)
60. Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res 2006;23:1417-1450 (Pubitemid 43993807)
61. Langer R. Drug delivery and targeting. Nature 1998;392(6679):5-10
62. Warenius HM, Galfre G, Bleehen NM, et al. Attempted targeting of a monoclonal-antibody in a human-tumor xenograft system. Eur J Cancer Clin Oncol 1981;17:1009-1015 (Pubitemid 11017860)
63. Albanell J, Baselga J. Trastuzumab, a humanized anti-HER2 monoclonal antibody for the treatment of breast cancer. Drugs Today 1999;35:931-946 (Pubitemid 30095596)
64. Ferrara N. VEGF as a therapeutic target in cancer. Oncology 2005;69(Suppl 3):11-16
65. Carter P. Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001;1:118-129 (Pubitemid 33741887)
66. Baselga J, Norton L, Albanell J, et al. Recombinant humanized anti-HER2 antibody (HerceptinTM) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 1998;58:2825-2831 (Pubitemid 28311914)
67. Sapra P, Allen TM. Ligand-targeted liposomal anticancer drugs. Prog Lipid Res 2003;42(5):439-462
68. Gatter KC. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 1983;36(5):539-545
69. Gu FX, Karnik R, Wang AZ, et al. Targeted nanoparticles for cancer therapy. Nano Today 2007;2(3):14-21
70. Nagy A, Schally AV. Targeting cytotoxic conjugates of somatostatin, luteinizing hormone-releasing hormone and bombesin to cancers expressing their receptors: a 'smarter' chemotherapy. Curr Pharm Design 2005;11(9):1167-1180
71. Stella B, Arpicco S, Peracchia MT, et al. Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 2000;89:1452-1464 (Pubitemid 30805251)
72. O'Reilly RK, Joralemon MJ, Hawker CJ, et al. Facile syntheses of surface-functionalized micelles and shell cross-linked nanoparticles. J Polymer Sci A Polym Chem 2006;44(17):5203-5217
73. Luo LB, Tam J, Maysinger D, et al. Cellular internalization of poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles. Bioconjug Chem 2002;13(6):1259-1265 (Pubitemid 35420018)
74. Savic R, Luo LB, Eisenberg A, et al. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003;300(5619):615-618 (Pubitemid 36520581)
75. Desset S, Spalla O, Lixon P, et al. From powders to dispersions in water: effect of adsorbed molecules on the redispersion of alumina particles. Langmuir 2001;17(21):6408-6418 (Pubitemid 35330619)
76. Caruso F, Caruso RA, Mohwald H. Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating. Science 1998;282(5391):1111-1114 (Pubitemid 28516238)
77. Filali M, Meier MAR, Schubert US, et al. Star-block copolymers as templates for the preparation of stable gold nanoparticles. Langmuir 2005;21(17):7995-8000 (Pubitemid 44323832)
78. Kim BS, Qiu JM, Wang JP, et al. Magnetomicelles: composite nanostructures from magnetic nanoparticles and cross-linked amphiphilic block copolymers. Nano Lett 2005;5(10):1987-1991
79. Gupta AK, Curtis ASG. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials 2004;25(15):3029-3040
80. Paciotti GF, Myer L, Weinreich D, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 2004;11(3):169-183 (Pubitemid 38720414)
81. Alexiou C, Jurgons R, Seliger G, et al. Medical applications of magnetic nanoparticles. J Nanosci Nanotechnol 2006;6(9-10):2762-2768
82. Wang H, Huff TB, Zweifel DA, et al. In vitro and in vivo two-photon luminescence imaging of single gold nanorods. Proc Natl Acad Sci USA 2005;102(44):15752-15756
83. Loo C, Lowery A, Halas N, et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005;5:709-711 (Pubitemid 40609745)
84. Lee JH, Jun YW, Yeon SI, et al. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angew Chem Int Ed 2006;45(48):8160-8162
85. Lee HY, Li Z, Chen K, et al. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med 2008;49(8):1371-1379
86. Cheon J, Lee JH. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res 2008;141(12):1630-1640
87. Rotello V. Nanoparticles. Building blocks for nanotechnology. In: Lockwood DJ, editor, Nanostructure Science and Technology. Springer Science+Business Media, Inc., New York, NY; 2004
88. Nasongkla N, Bey E, Ren JM, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006;6(11):2427-2430
89. Yang J, Lee CH, Park J, et al. Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer. J Mater Chem 2007;17(26):2695-2705
90. Liu J, Lee H, Allen C. Formulation of drugs in block copolymer micelles: drug loading and release. Curr Pharm Des 2006;12(36):4685-4701 (Pubitemid 44835137)
91. Johnson BK. Flash nanoprecipitation of organic actives via confined micromixing and block copolymer stabilization, in department of chemical engineering. Princeton University: Princeton; 2003
92. Gindy ME, Panagiotopoulos AZ, Prud'homme RK. Composite block copolymer stabilized nanoparticles: simultaneous encapsulation of organic actives and inorganic nanostructures. Langmuir 2008;24(1):83-90
93. Brick MC, Palmer HJ, Whitesides TH. Formation of colloidal dispersions of organic materials in aqueous media by solvent shifting. Langmuir 2003;19(16):6367-6380
94. Liu Y, Cheng CY, Prud'homme RK, et al. Mixing in a multi-inlet vortex mixer (MIVM) for flash nanoprecipitation. Chem Eng Sci 2007;63(11):2829-2842
95. Gindy ME. Modular approach toward multifunctional nanoparticles for integrated drug delivery, targeting and diagnostics, in chemical engineering. Princeton University: Princeton; 2008
96. Ungun B, Prud'homme RK, Budijono SJ, et al. Nanofabricated upconversion nanoparticles for photodynamic therapy. Opt Expr 2009;17(1):80-86
97. Akbulut M, Ginart P, Gindy ME, et al. Generic method for preparing multifunctional fluorescent nanoparticles using flash nanoprecipitation. Adv Funct Mater 2009;19(5):718-725
98. Gindy ME, Ji SX, Hoye TR, et al. Preparation of poly(ethylene glycol) protected nanoparticles with variable bioconjugate ligand density. Biomacromolecules 2008;9:2705-2711
99. Bartlett DW, Su H, Hildebrandt IJ, et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 2007;104(39):15549-15554 (Pubitemid 47502954)
100. Johnson BK, Prud'homme RK. Flash nanoprecipitation of organic actives and block copolymers using a confined impinging jets mixer. Aust J Chem 2003;56(10):1021-1024
101. Horn D, Rieger J. Organic nanoparticles in the aqueous phase - theory, experiment, and use. Angew Chem Int Ed 2001;40(23):4330-4361 (Pubitemid 33150759)
102. Liu Y. Formulating nanoparticles by flash nanoprecipitation for drug delivery and sustained release., in PhD Thesis, department of chemical engineering. Princeton University; 2007